Anti-Prm Antibody as an Autoantibody in Dengue Virus Infection
Kao-Jean Huang1, Yu-Tien Cheng1, Yee-Shin Lin1, Jyh-Hsiung Huang2, Hsiao-Sheng Liu1, Trai-Ming Yeh1, Ching-Chuan Liu1 & Huan-Yao Lei1 Show affiliations
- National Cheng Kung University, Taiwan
- Center for Disease Control, China
American Journal of Infectious Diseases, Volume 4, Issue 1, pp. 60–68 · doi.org/10.3844/ajidsp.2008.60.68
Abstract
We have reported that anti-prM antibody is an enhancing antibody that enhances DV infection of non-Fc receptor bearing cells by dual specificity. We identified the epitope recognized by this anti-prM antibody, M3, which is located at the a.a.53-67of the prM protein nearby the prM/M cleavage junction and these anti-M3 antibodies could be detected in dengue patients sera. Surprisingly, this anti-prM antibody not only recognizes the prM protein of dengue virions, but also cross-reacts with epithelial cells, endothelial cells as well as T cells. The binding of anti-prM antibody to endothelial cells was dose-dependent and could be blocked by M3 peptides. Human M3-specific antibodies from dengue patient sera were demonstrated to be able to bind to endothelial cells and mediate ADE infection on K562 cells. Furthermore, the anti-prM antibody will mediate the antibody - dependent cell phagocytosis, leading to the similar severe form of DHF/DSS. In conclusion, anti-prM antibody plays two roles in the pathogenesis of dengue virus infection: to be an enhancing antibody and an autoantibody as well.
Licence and reuse
Free to read. This article carries the publisher’s copyright, as printed on it: © 2008 Science Publications. It is free to read; ask us before reusing it.
How to reuse this articleResponses (0)
About this article
Huang, K., Cheng, Y., Lin, Y., Huang, J., Liu, H., Yeh, T., Liu, C. & Lei, H. (2008). Anti-Prm Antibody as an Autoantibody in Dengue Virus Infection. American Journal of Infectious Diseases, 4(1), 60–68. https://doi.org/10.3844/ajidsp.2008.60.68
- Licence
- © Science Publications
- Issue
- Volume 4, Issue 1
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record
